Return to Listing

1 result(s) for

PI Name Protocol # Title
Shivaani Kummar STUDY00021349 A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) in Subjects With Selected Tumor Types

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080